REVERSAL OF ALUMINUM-RELATED BONE-DISEASE AFTER SUBSTITUTING CALCIUM-CARBONATE FOR ALUMINUM HYDROXIDE

被引:25
|
作者
HERCZ, G
ANDRESS, DL
NEBEKER, HG
SHINABERGER, JH
SHERRARD, DJ
COBURN, JW
机构
[1] VET ADM WADSWORTH MED CTR, MED SERV, NEPHROL SECT 691-111L, WILSHIRE & SAWTELLE BLVD, LOS ANGELES, CA 90073 USA
[2] VET ADM WADSWORTH MED CTR, RES SERV, LOS ANGELES, CA 90073 USA
[3] UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA
[4] UNIV WASHINGTON, SCH MED, SEATTLE, WA 98195 USA
[5] VET ADM MED CTR, MED SERV, SEATTLE, WA 98108 USA
关键词
D O I
10.1016/S0272-6386(88)80179-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:70 / 75
页数:6
相关论文
共 50 条
  • [31] LOW-DOSE DESFERRIOXAMINE TEST FOR THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE IN PATIENTS ON REGULAR HEMODIALYSIS
    YAQOOB, M
    AHMAD, R
    ROBERTS, N
    HELLIWELL, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (07) : 484 - 486
  • [32] CLINICAL AND LABORATORY FEATURES OF ALUMINUM-RELATED BONE-DISEASE - DIFFERENCES BETWEEN SPORADIC AND EPIDEMIC FORMS OF THE SYNDROME
    NORRIS, KC
    CROOKS, PW
    NEBEKER, HG
    HERCZ, G
    MILLINER, DS
    GERSZI, K
    SLATOPOLSKY, E
    ANDRESS, DL
    SHERRARD, DJ
    COBURN, JW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 6 (05) : 342 - 347
  • [33] EFFECTS OF MAGNESIUM-ALUMINUM HYDROXIDE AND CALCIUM-CARBONATE ANTACIDS ON BIOAVAILABILITY OF OFLOXACIN
    FLOR, S
    GUAY, DRP
    OPSAHL, JA
    TACK, K
    MATZKE, GR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) : 2436 - 2438
  • [34] HIGH-DOSE PHOSPHATE BINDERS - CALCIUM-CARBONATE VERSUS ALUMINUM HYDROXIDE
    ZATUCHNI, J
    BRITISH MEDICAL JOURNAL, 1985, 291 (6505): : 1355 - 1355
  • [35] USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD
    DHAESE, PC
    COUTTENYE, MM
    GOODMAN, WG
    LEMONIATOU, E
    DIGENIS, P
    SOTORNIK, I
    FAGALDE, A
    BARSOUM, RS
    LAMBERTS, LV
    DEBROE, ME
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (10) : 1874 - 1884
  • [36] Aluminum-related bone disease in an hemodialyzed patient treated with sucralfate
    Level, C
    dePrecigout, V
    Larroumet, N
    Blanchetier, V
    Potaux, L
    Aparicio, M
    REVUE DE MEDECINE INTERNE, 1996, 17 (04): : 348 - 349
  • [37] ALUMINUM AND TPN-RELATED BONE-DISEASE - REPLY
    KOO, WWK
    CHESNEY, RW
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (02): : 484 - 485
  • [38] ALUMINUM AND DIALYSIS BONE-DISEASE
    COURNOTWITMER, G
    ZINGRAFF, J
    BOURDON, R
    DRUEKE, T
    BALSAN, S
    LANCET, 1979, 2 (8146): : 795 - 796
  • [39] ALUMINUM RELATED BONE-DISEASE - HIGH PREVALENCE DESPITE LOW DIALYSATE ALUMINUM
    COOPER, K
    LANG, R
    ELLISON, A
    HENDLER, E
    FAUGERE, MC
    MALLUCHE, H
    BIA, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 92 - 92
  • [40] CONTROL OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS - COMPARISON OF ALUMINUM HYDROXIDE, CALCIUM-CARBONATE, AND MAGNESIUM TRISILICATE
    MACTIER, RA
    LEUNG, ACT
    HENDERSON, IS
    DOBBIE, JW
    DIALYSIS & TRANSPLANTATION, 1987, 16 (11) : 599 - 601